Page 5 - 2019_04-Haematologica-web
P. 5

Table of Contents
Volume 104, Issue 4: April 2019
Cover Figure
haematologica Journal of the Ferrata Storti Foundation
Bone marrow smear from a patient with atypical chronic myeloid leukemia, BCR-ABL1 negative, showing abnormal chromatin clumping, hyosegmented nuclei, and agranular cytoplasm in late granulocytic cells. Courtesy of Prof. Rosangela Invernizzi.
Editorials
639 Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms Naoimh Herlihy et al.
642 Expounding on the essence of epigenetic and genetic abnormalities in blastic plasmacytoid dendritic cell neoplasms Lhara Lezama et al.
644 THROMBOTECT takes the lead Christoph Male et al.
646 Asymmetric dimethylarginine – a prognostic marker for transplant outcome? Janghee Woo and H. Joachim Deeg
Perspective Article
648 Liquid biopsy in lymphoma Davide Rossi et al.
Review Articles
653 Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis Victor R. Gordeuk et al.
659 State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019 Donal P. McLornan et al.
Articles
Hematopoiesis
669 In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis Eva-Maria Demmerath et al.
Iron Metabolism & its Disorders
678 Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess Courtney J. Mercadante et al.
Red Cell Biology & its Disorders
690 Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease Lena Václavuo et al.
Myelodysplastic Syndromes
700 Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia Melita Kenealy et al.
Myeloproliferative Neoplasms
710 The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14
Beatrice Drexler et al.
Chronic Myeloid Leukemia
717 A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia Roberto Bernardoni et al.
Myeloid Neoplasms
Haematologica 2019; vol. 104 no. 4 - April 2019 http://www.haematologica.org/


































































































   3   4   5   6   7